Stock screener

AUTL

Conviction 69HealthcareScan · Fri, Jun 26, 2026
AUTL$1.63+2.20%
ResistanceSupportVol 14
63 bars
Vol MA14 1.04M
Mar 27Apr 15May 4May 20Jun 9Jun 26
Autolus Therapeutics plcBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.autolus.com
Price1.63
Change+2.20%
Gap+1.26%
Rel volume0.46×
Avg volume1.22M
Avg $ vol1.97M
SMA 201.59
SMA 501.59
SMA 2001.53
Price vs 50+2.07%
Price vs 200+6.07%
MA stackbullish
50/200 cross
Supertrendup · 1.44
RSI (14)53
MACD hist0.01
MACD crossbull · 2d
Stoch %K / %D82 / 69
ADX (14)18
+DI / −DI21 / 14
RSI divergence
MACD divergence
ATR %+7.17%
ADR %7.56%
52w high2.68
52w low1.21
From 52w high-39.37%
Above 52w low+34.30%
New 52w highNo
SqueezeOff
Bollinger width29.13%
%B0.58
Donchian pos48.25%
Donchian high1.89
Donchian low1.38
AVWAP (52w high)1.58
vs AVWAP high+2.67%
AVWAP (52w low)1.56
vs AVWAP low+4.41%
OBV trendDown
Chaikin MF (20)-0.18
Today vs 20d0.46×
Avg vol (14d)1.04M
Avg vol (20d)1.22M
Avg $ vol (20d)1.97M
Market cap
RS 3m (vs SPY)+7.75%
RS 6m (vs SPY)-15.32%
RS line new highNo
Trend template6/8
Technical rank44.9
1 week+7.62%
1 month-3.27%
3 months+25.97%
6 months-0.91%
1 year-29.96%
YTD-13.10%
P/E-1.49
P/B3.93
P/S5.67
P/FCF-1.41
EPS-1.08
Div yield
ROE-264.21%
ROA-54.55%
Debt/Eq0.00
Current5.80
EV/EBITDA-1.13
Gross margin
Net margin-381.40%
Rev growth644.94%
EPS growth-30.30%
Price target
Target upside
Analyst rating
Institutional
Ent. value296.26M
Revenue26.22M
Net income-71.6M
Gross profit
Free cash flow-302.61M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out266.16M
Employees752
ListedFri, Jun 22, 2018
Free float
Float %
Short interest
Days to cover
Short volume
Squeeze score
Next earnings
EPS forecast
Last EPS vs est
Last surprise
Setup gradeB
Conviction69 / 100
Pattern quality
Tech rank44.9 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction
Pattern family
Resistance1.92
Support1.41
Days since event
Candle confirm
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in AUTL

All disclosures →
No recent disclosed trades by Congress in AUTL. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in AUTL

No recent insider (Form 4) filings in AUTL. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in AUTL · 1 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.